Antitumor activity of interleukin-21 prepared by novel refolding procedure from inclusion bodies expressed in Escherichia coli

Medicine and Dentistry

• Human 100%
• Cytokine 66%
• Escherichia coli 50%
• Interleukin 21 50%
• Antineoplastic Activity 33%
• Helix 33%
• Co-Stimulation 33%
• Peripheral Blood Mononuclear Cell 16%
• Immune Response 16%
• Spectroscopy 16%
• Cholangiocarcinoma 16%
• Flow Cytometry 16%
• Cytotoxicity 16%
• Growth Inhibition 16%
• Reagent 16%
• Circular Dichroism 16%
• Protein Secondary Structure 16%
• HL60 16%
• Raji Cell 16%
• CD3 Antibody 16%
• Adoptive Immunotherapy 16%
• Recombinant Interleukin 21 16%
• Cells 16%
• Assay 16%
• T Cell 16%
• Cytokine Receptor 16%

Immunology and Microbiology

• Human 100%
• Escherichia coli 50%
• Interleukin 21 50%
• Antineoplastic Activity 33%
• Inclusion Bodies 33%
• Peripheral Blood Mononuclear Cell 16%
• Immune Response 16%
• Electric Potential 16%
• Cytotoxicity 16%
• Growth Inhibition 16%
• Protein Secondary Structure 16%
• Raji Cell Line 16%
• Spectrum 16%
• Dialysis 16%
• CD3 Antibody 16%
• Cells 16%
• Flow 16%
• Adoptive Immunotherapy 16%
• Recombinant Interleukin 21 16%
• Cytokine Receptor 16%